Clinical Trials Directory

Trials / Unknown

UnknownNCT00844389

Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy

Near to Infrared Light Stimulation Effect on Ganglion Cell Function in Glaucomatous Optic Neuropathy

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Universidad de Valparaiso · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate if near-to-infrared light stimulation can improve retinal ganglion cell function in glaucomatous patients.

Detailed description

Ganglion cell dysfunction in glaucomatous optic neuropathy has been ascribed to ganglion cell electrophysiological inactivation and to apoptotic cell death. Near-to-infrared light stimulation has been used to induce mitochondrial activation and to prevent apoptotic death through mitochondrial cytochrome oxidase c stimulation. Near-to-infrared light stimulation might be useful to induce ganglion cell activation and inhibit apoptotic cell death. We propose that near-to-infrared light stimulation can be used as an adjuvant treatment combined with ocular hypotensive treatment in glaucomatous patients.

Conditions

Interventions

TypeNameDescription
DEVICENear to infrared light retinal stimulationPatients will be stimulated with 660 nm light frequency through a LED device. Patients will be stimulated daily for two minutes for a 6 month period.
DEVICEGreen light stimulationPatients will be stimulated with 530 nm LED light frequency through a LED device. Patients will be stimulated daily for two minutes for a 6 month period.

Timeline

Start date
2009-04-01
Primary completion
2009-12-01
Completion
2010-03-01
First posted
2009-02-16
Last updated
2009-10-01

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT00844389. Inclusion in this directory is not an endorsement.